| scholarly article | Q13442814 |
| P2093 | author name string | X. Zhang | |
| Y. Zhou | |||
| A. Klibanski | |||
| P2860 | cites work | A Pituitary-Derived MEG3 Isoform Functions as a Growth Suppressor in Tumor Cells | Q24299283 |
| Activation of p53 by MEG3 non-coding RNA | Q24310760 | ||
| Mdm2 promotes the rapid degradation of p53 | Q24322597 | ||
| Mfold web server for nucleic acid folding and hybridization prediction | Q24498105 | ||
| Maternally expressed gene 3 (MEG3) noncoding ribonucleic acid: isoform structure, expression, and functions | Q24623420 | ||
| BRCA1 regulates p53-dependent gene expression | Q24685083 | ||
| Regulation of p53 stability by Mdm2 | Q27860744 | ||
| Expanded sequence dependence of thermodynamic parameters improves prediction of RNA secondary structure | Q27860806 | ||
| WAF1, a potential mediator of p53 tumor suppression | Q27861121 | ||
| Maternally expressed gene 3, an imprinted noncoding RNA gene, is associated with meningioma pathogenesis and progression | Q28115872 | ||
| Selective loss of MEG3 expression and intergenic differentially methylated region hypermethylation in the MEG3/DLK1 locus in human clinically nonfunctioning pituitary adenomas | Q28117410 | ||
| Loss of expression of GADD45 gamma, a growth inhibitory gene, in human pituitary adenomas: implications for tumorigenesis | Q28206371 | ||
| Pref-1, a protein containing EGF-like repeats, inhibits adipocyte differentiation | Q28269495 | ||
| Activation of paternally expressed genes and perinatal death caused by deletion of the Gtl2 gene | Q28585506 | ||
| Deletion of Gtl2, imprinted non-coding RNA, with its differentially methylated region induces lethal parent-origin-dependent defects in mice | Q28588399 | ||
| Increased expression of angiogenic genes in the brains of mouse meg3-null embryos | Q28590418 | ||
| The mouse Gtl2 gene is differentially expressed during embryonic development, encodes multiple alternatively spliced transcripts, and may act as an RNA | Q28594499 | ||
| Differential regulation of imprinting in the murine embryo and placenta by the Dlk1-Dio3 imprinting control region | Q29036897 | ||
| Blinded by the Light: The Growing Complexity of p53 | Q29547590 | ||
| Role of angiogenesis in tumor growth and metastasis | Q29614309 | ||
| The p53 pathway: positive and negative feedback loops | Q29617535 | ||
| Effects of an Rb mutation in the mouse | Q29619196 | ||
| Gonadotropinomas | Q30310432 | ||
| The IG-DMR and the MEG3-DMR at human chromosome 14q32.2: hierarchical interaction and distinct functional properties as imprinting control centers | Q33619072 | ||
| VEGFs, receptors and angiogenesis | Q33644265 | ||
| TP53 mutations in human cancers: origins, consequences, and clinical use | Q33685392 | ||
| The ARF/p53 pathway | Q33840421 | ||
| Identification of an imprinted gene, Meg3/Gtl2 and its human homologue MEG3, first mapped on mouse distal chromosome 12 and human chromosome 14q. | Q33897694 | ||
| Clinically nonfunctioning pituitary tumors are monoclonal in origin | Q34256956 | ||
| Animal models of tumor-suppressor genes. | Q34432219 | ||
| Cyclic AMP stimulates MEG3 gene expression in cells through a cAMP-response element (CRE) in the MEG3 proximal promoter region | Q34540991 | ||
| The PTEN, Mdm2, p53 tumor suppressor-oncoprotein network | Q34825957 | ||
| The functional role of long non-coding RNA in human carcinomas | Q34995156 | ||
| Silencing of the imprinted DLK1-MEG3 locus in human clinically nonfunctioning pituitary adenomas | Q35235761 | ||
| Genomic imprinting at the mammalian Dlk1-Dio3 domain | Q37159981 | ||
| p53 regulation by ubiquitin | Q37882073 | ||
| TP53 mutations in human cancer: database reassessment and prospects for the next decade | Q37894331 | ||
| Epigenetic analysis of the Dlk1-Gtl2 imprinted domain on mouse chromosome 12: implications for imprinting control from comparison with Igf2-H19. | Q38293388 | ||
| Overexpression of the long non-coding RNA MEG3 impairs in vitro glioma cell proliferation | Q39414139 | ||
| Comparative sequence analysis of the imprinted Dlk1-Gtl2 locus in three mammalian species reveals highly conserved genomic elements and refines comparison with the Igf2-H19 region. | Q40415818 | ||
| Epigenetic alteration at the DLK1-GTL2 imprinted domain in human neoplasia: analysis of neuroblastoma, phaeochromocytoma and Wilms' tumour | Q40441171 | ||
| A human pituitary tumor-derived folliculostellate cell line | Q40893501 | ||
| microRNA-29 can regulate expression of the long non-coding RNA gene MEG3 in hepatocellular cancer | Q41830068 | ||
| Requirement for a functional Rb-1 gene in murine development | Q44462954 | ||
| Clonal origin of pituitary adenomas | Q45035533 | ||
| Hypermethylation of the promoter region is associated with the loss of MEG3 gene expression in human pituitary tumors | Q45219910 | ||
| Asymmetric regulation of imprinting on the maternal and paternal chromosomes at the Dlk1-Gtl2 imprinted cluster on mouse chromosome 12. | Q48231351 | ||
| Clonal origins of adrenocorticotropin-secreting pituitary tissue in Cushing's disease | Q48415480 | ||
| Expression of cell growth negative regulators MEG3 and GADD45γ is lost in most sporadic human pituitary adenomas. | Q48944595 | ||
| Loss of Expression ofGADD45γ, a Growth Inhibitory Gene, in Human Pituitary Adenomas: Implications for Tumorigenesis | Q56602254 | ||
| High cancer susceptibility and embryonic lethality associated with mutation of the PTEN tumor suppressor gene in mice | Q58378937 | ||
| Tumor suppressor genes | Q68264184 | ||
| Tumor suppressor genes | Q72883741 | ||
| Loss of heterozygosity on chromosome 14 in nasopharyngeal carcinoma | Q77354036 | ||
| Loss of heterozygosity of 14q32 in colorectal carcinoma | Q77809187 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | R45-53 | |
| P577 | publication date | 2012-06-01 | |
| P1433 | published in | Journal of Molecular Endocrinology | Q15716709 |
| P1476 | title | MEG3 noncoding RNA: a tumor suppressor | |
| P478 | volume | 48 |
| Q89570941 | A Hearty Dose of Noncoding RNAs: The Imprinted DLK1-DIO3 Locus in Cardiac Development and Disease |
| Q47800026 | A Looking-Glass of Non-coding RNAs in oral cancer |
| Q36397264 | A Self-Training Subspace Clustering Algorithm under Low-Rank Representation for Cancer Classification on Gene Expression Data |
| Q57790083 | A Three-lncRNA Expression Signature Predicts Survival in Head and neck squamous cell carcinoma (HNSCC) |
| Q39041604 | A critical role for the long non-coding RNA GAS5 in proliferation and apoptosis in non-small-cell lung cancer |
| Q38378667 | A molecular conundrum involving hypothalamic responses to and roles of long non-coding RNAs following food deprivation |
| Q35086900 | A network based method for analysis of lncRNA-disease associations and prediction of lncRNAs implicated in diseases |
| Q33898799 | A novel long non-coding RNA FOXCUT and mRNA FOXC1 pair promote progression and predict poor prognosis in esophageal squamous cell carcinoma |
| Q57027004 | A novel long noncoding RNA HOXC-AS3 mediates tumorigenesis of gastric cancer by binding to YBX1 |
| Q58727464 | A novel molecular mechanism for a long non-coding RNA PCAT92 implicated in prostate cancer |
| Q33983698 | A novel reannotation strategy for dissecting DNA methylation patterns of human long intergenic non-coding RNAs in cancers |
| Q37705864 | A potential prognostic lncRNA signature for predicting survival in patients with bladder urothelial carcinoma |
| Q40121556 | Aberrant Methylation of MEG3 Functions as a Potential Plasma-Based Biomarker for Cervical Cancer |
| Q47322610 | Aberrant lncRNA Expression in Multiple Myeloma |
| Q54537800 | An Immune-Related Six-lncRNA Signature to Improve Prognosis Prediction of Glioblastoma Multiforme. |
| Q26753467 | An overview of long non-coding RNAs in ovarian cancers |
| Q36145048 | Analysis of SOX2-Regulated Transcriptome in Glioma Stem Cells |
| Q90352972 | Angio-LncRs: LncRNAs that regulate angiogenesis and vascular disease |
| Q55021652 | Anticancer Properties of Fenofibrate: A Repurposing Use. |
| Q36997737 | Approaches to uncovering cancer diagnostic and prognostic molecular signatures |
| Q37269190 | Armored long non-coding RNA MEG3 targeting EGFR based on recombinant MS2 bacteriophage virus-like particles against hepatocellular carcinoma |
| Q60936828 | Association between MEG3/miR-181b polymorphisms and risk of ischemic stroke |
| Q52655194 | Association between long non-coding RNAs expression and pathogenesis and progression of gliomas. |
| Q93128715 | Association of LncRNA MEG3 polymorphisms with efficacy of neoadjuvant chemotherapy in breast cancer |
| Q36261857 | Association of long non-coding RNA HOTTIP with progression and prognosis in colorectal cancer |
| Q52609034 | Associations between lncRNA MEG3 polymorphisms and neuroblastoma risk in Chinese children. |
| Q37109931 | Associations between polymorphisms of long non-coding RNA MEG3 and risk of colorectal cancer in Chinese |
| Q28591066 | Ataxia and Purkinje cell degeneration in mice lacking the CAMTA1 transcription factor |
| Q49497915 | Behind the curtain of non-coding RNAs; long non-coding RNAs regulating hepatocarcinogenesis. |
| Q38957351 | CCAT1: an oncogenic long noncoding RNA in human cancers |
| Q37710652 | CRISPR/Cas9-mediated heterozygous knockout of the autism gene CHD8 and characterization of its transcriptional networks in cerebral organoids derived from iPS cells |
| Q90137081 | Cadmium exposure and MEG3 methylation differences between Whites and African Americans in the NEST Cohort |
| Q33744631 | Cell cycle, oncogenic and tumor suppressor pathways regulate numerous long and macro non-protein-coding RNAs |
| Q38168041 | Characteristics of long non-coding RNA and its relation to hepatocellular carcinoma |
| Q64245279 | CircHMGCS1 Promotes Hepatoblastoma Cell Proliferation by Regulating the IGF Signaling Pathway and Glutaminolysis |
| Q43653975 | Clinical significance of the low expression of FER1L4 in gastric cancer patients |
| Q54777296 | Comparative pan-cancer DNA methylation analysis reveals cancer common and specific patterns. |
| Q38302313 | Comparative transcriptome analysis of epithelial and fiber cells in newborn mouse lenses with RNA sequencing |
| Q27302327 | Complex network analysis of CA3 transcriptome reveals pathogenic and compensatory pathways in refractory temporal lobe epilepsy |
| Q91292029 | Comprehensive Analysis of the Expression Profiles of Long Non-Coding RNAs with Associated ceRNA Network Involved in the Colon Cancer Staging and Progression |
| Q90125452 | Comprehensive Characterization of Somatic Mutations Impacting lncRNA Expression for Pan-Cancer |
| Q49325078 | Comprehensive analysis of mRNA-lncRNA co-expression profile revealing crucial role of imprinted gene cluster DLK1-MEG3 in chordoma. |
| Q36184525 | Comprehensive clinical studies in 34 patients with molecularly defined UPD(14)pat and related conditions (Kagami-Ogata syndrome) |
| Q64922761 | Comprehensive functional profiling of long non-coding RNAs through a novel pan-cancer integration approach and modular analysis of their protein-coding gene association networks. |
| Q35142587 | Concomitant downregulation of the imprinted genes DLK1 and MEG3 at 14q32.2 by epigenetic mechanisms in urothelial carcinoma |
| Q57789222 | Connivance, Complicity, or Collusion? The Role of Noncoding RNAs in Promoting Gammaherpesvirus Tumorigenesis |
| Q92830282 | Conserved Pseudoknots in lncRNA MEG3 Are Essential for Stimulation of the p53 Pathway |
| Q49922983 | Critical effects of long non-coding RNA on fibrosis diseases. |
| Q36841340 | Crosstalk between Meg3 and miR-1297 regulates growth of testicular germ cell tumor through PTEN/PI3K/AKT pathway |
| Q38717405 | Curcumin suppresses cisplatin resistance development partly via modulating extracellular vesicle-mediated transfer of MEG3 and miR-214 in ovarian cancer |
| Q49273546 | Current research on head and neck cancer-associated long noncoding RNAs. |
| Q55668617 | DEPTOR regulates osteogenic differentiation via inhibiting MEG3-mediated activation of BMP4 signaling and is involved in osteoporosis. |
| Q38237444 | DLK1-DIO3 imprinted cluster in induced pluripotency: landscape in the mist |
| Q34363848 | Databases for lncRNAs: a comparative evaluation of emerging tools |
| Q55668859 | Deciphering Non-coding RNAs in Cardiovascular Health and Disease. |
| Q54975879 | Deciphering the roles of lncRNAs in breast development and disease. |
| Q41054929 | Decreased expression of MEG3 contributes to retinoblastoma progression and affects retinoblastoma cell growth by regulating the activity of Wnt/β-catenin pathway |
| Q36520223 | Decreased expression of long non-coding RNA GAS5 indicates a poor prognosis and promotes cell proliferation and invasion in hepatocellular carcinoma by regulating vimentin |
| Q36464861 | Decreased expression of long non-coding RNA MEG3 acts as a potential predictor biomarker in progression and poor prognosis of osteosarcoma |
| Q33618023 | Decreased expression of long noncoding RNA GAS5 indicates a poor prognosis and promotes cell proliferation in gastric cancer |
| Q38914926 | Decreased expression of long noncoding RNA MEG3 affects cell proliferation and predicts a poor prognosis in patients with colorectal cancer |
| Q37598887 | Decreased expression of pseudogene PTENP1 promotes malignant behaviours and is associated with the poor survival of patients with HNSCC. |
| Q48097529 | Deregulated expression of long non-coding RNA UCA1 in multiple myeloma |
| Q52725331 | Deregulation of linc-PINT in acute lymphoblastic leukemia is implicated in abnormal proliferation of leukemic cells. |
| Q58612047 | Deregulation of the imprinted DLK1-DIO3 locus ncRNAs is associated with replicative senescence of human adipose-derived stem cells |
| Q92130384 | Diabetic Retinopathy, lncRNAs, and Inflammation: A Dynamic, Interconnected Network |
| Q52633625 | Differential expression and prognostic value of long non-coding RNA in HPV-negative head and neck squamous cell carcinoma. |
| Q37159825 | Discovery of potential prognostic long non-coding RNA biomarkers for predicting the risk of tumor recurrence of breast cancer patients |
| Q35966084 | Distinct temporal changes in host cell lncRNA expression during the course of an adenovirus infection |
| Q36499296 | Down regulated lncRNA MEG3 eliminates mycobacteria in macrophages via autophagy |
| Q39215101 | Downregulated MEG3 activates autophagy and increases cell proliferation in bladder cancer |
| Q91729365 | Downregulated MEG3 participates in rheumatoid arthritis via promoting proliferation of fibroblast-like synoviocytes |
| Q45903254 | Downregulated long noncoding RNA MEG3 is associated with poor prognosis and promotes cell proliferation in gastric cancer. |
| Q36524087 | Downregulation of BC200 in ovarian cancer contributes to cancer cell proliferation and chemoresistance to carboplatin |
| Q34998951 | Downregulation of GAS5 promotes bladder cancer cell proliferation, partly by regulating CDK6. |
| Q39096980 | Downregulation of gas5 increases pancreatic cancer cell proliferation by regulating CDK6. |
| Q38813218 | Downregulation of lncRNA-MALAT1 Affects Proliferation and the Expression of Stemness Markers in Glioma Stem Cell Line SHG139S. |
| Q47156458 | Downregulation of the Long Non-Coding RNA Meg3 Promotes Angiogenesis After Ischemic Brain Injury by Activating Notch Signaling |
| Q37151282 | Downregulation of the long noncoding RNA GAS5-AS1 contributes to tumor metastasis in non-small cell lung cancer |
| Q37375136 | Dysregulated Expression of Long Noncoding RNAs in Ovarian Cancer |
| Q37582014 | Dysregulation of MALAT1 and miR-619-5p as a prognostic indicator in advanced colorectal carcinoma |
| Q34178419 | Emerging paradigms of long non-coding RNAs in gastrointestinal cancer |
| Q35138074 | Epigenetic and transcriptional determinants of the human breast |
| Q35738521 | Epigenetic regulation of Newborns' imprinted genes related to gestational growth: patterning by parental race/ethnicity and maternal socioeconomic status. |
| Q100512217 | Epigenetic regulation of VENTXP1 suppresses tumor proliferation via miR-205-5p/ANKRD2/NF-kB signaling in head and neck squamous cell carcinoma |
| Q35054978 | Epigenetic regulation of the lncRNA MEG3 and its target c-MET in pancreatic neuroendocrine tumors |
| Q33913401 | Epigenetic silencing of genes and microRNAs within the imprinted Dlk1-Dio3 region at human chromosome 14.32 in giant cell tumor of bone |
| Q37696142 | Epigenetic silencing of tumor suppressor long non-coding RNA BM742401 in chronic lymphocytic leukemia. |
| Q42115029 | Epigenetics of gastroenteropancreatic neuroendocrine tumors: A clinicopathologic perspective |
| Q33677918 | Exploring functions of long noncoding RNAs across multiple cancers through co-expression network |
| Q87161553 | Expression and mechanisms of long non-coding RNA genes MEG3 and ANRIL in gallbladder cancer |
| Q28553467 | Expression of the lncRNA Maternally Expressed Gene 3 (MEG3) Contributes to the Control of Lung Cancer Cell Proliferation by the Rb Pathway |
| Q54225798 | Expression of the long non-coding RNAs MEG3, HOTAIR, and MALAT-1 in non-functioning pituitary adenomas and their relationship to tumor behavior. |
| Q33721461 | Expression pattern of long non-coding RNAs in renal cell carcinoma revealed by microarray |
| Q90700351 | Expression profile analysis of antisense long non-coding RNA identifies WDFY3-AS2 as a prognostic biomarker in diffuse glioma |
| Q53078040 | Expression, regulation and roles of miR-26a and MEG3 in tongue squamous cell carcinoma. |
| Q38287045 | Focusing on long noncoding RNA dysregulation in gastric cancer |
| Q91584672 | Functional impact of the long non-coding RNA MEG3 deletion by CRISPR/Cas9 in the human triple negative metastatic Hs578T cancer cell line |
| Q40574364 | Gene Signature of Human Oral Mucosa Fibroblasts: Comparison with Dermal Fibroblasts and Induced Pluripotent Stem Cells |
| Q37619445 | Genetic and epigenetic mutations of tumor suppressive genes in sporadic pituitary adenoma |
| Q39036921 | Genome-Wide DNA Methylation Patterns Analysis of Noncoding RNAs in Temporal Lobe Epilepsy Patients |
| Q28729088 | Genome-wide characterization of menin-dependent H3K4me3 reveals a specific role for menin in the regulation of genes implicated in MEN1-like tumors |
| Q90751515 | Genome-wide discovery and characterization of long noncoding RNAs in patients with multiple myeloma |
| Q90027811 | Genome-wide identification of lncRNAs and mRNAs differentially expressed in non-functioning pituitary adenoma and construction of an lncRNA-mRNA co-expression network |
| Q33557802 | H3K27 acetylation activated-long non-coding RNA CCAT1 affects cell proliferation and migration by regulating SPRY4 and HOXB13 expression in esophageal squamous cell carcinoma |
| Q33898623 | High expression of lncRNA MALAT1 suggests a biomarker of poor prognosis in colorectal cancer |
| Q64260073 | How Does Reprogramming to Pluripotency Affect Genomic Imprinting? |
| Q41690525 | Human Long Noncoding RNA Regulation of Stem Cell Potency and Differentiation. |
| Q47140199 | Hypermethylation of MEG3 promoter correlates with inactivation of MEG3 and poor prognosis in patients with retinoblastoma |
| Q40576605 | IDH1 mutation-associated long non-coding RNA expression profile changes in glioma |
| Q28397795 | Identification and characterization of lncRNA mediated transcriptional dysregulation dictates lncRNA roles in glioblastoma |
| Q36053910 | Identification and validation of potential prognostic lncRNA biomarkers for predicting survival in patients with multiple myeloma. |
| Q55018738 | Identification of genes directly responding to DLK1 signaling in Callipyge sheep. |
| Q61804801 | Identification of long non-coding RNA-related and -coexpressed mRNA biomarkers for hepatocellular carcinoma |
| Q33758560 | Identification of sexually dimorphic genes in the neonatal mouse cortex and hippocampus |
| Q43375955 | Identifying Novel Glioma-Associated Noncoding RNAs by Their Expression Profiles |
| Q90712414 | Integrated analysis of co-expression and ceRNA network identifies five lncRNAs as prognostic markers for breast cancer |
| Q35620383 | Integrative Analysis of Normal Long Intergenic Non-Coding RNAs in Prostate Cancer |
| Q37376448 | Integrative analysis reveals clinical phenotypes and oncogenic potentials of long non-coding RNAs across 15 cancer types |
| Q64968817 | Interfering histone deacetylase 4 inhibits the proliferation of vascular smooth muscle cells via regulating MEG3/miR-125a-5p/IRF1. |
| Q35042300 | Involvement of long non-coding RNA in colorectal cancer: From benchtop to bedside (Review) |
| Q39278682 | LINC00152: A pivotal oncogenic long non-coding RNA in human cancers. |
| Q36375156 | Lateral ventricle injection of orexin-A ameliorates central precocious puberty in rat via inhibiting the expression of MEG3 |
| Q89967026 | LincRNA00494 Suppresses Non-small Cell Lung Cancer Cell Proliferation by Regulating SRCIN1 Expression as a ceRNA |
| Q33926034 | LncRNA MEG3 downregulation mediated by DNMT3b contributes to nickel malignant transformation of human bronchial epithelial cells via modulating PHLPP1 transcription and HIF-1α translation |
| Q52822414 | LncRNA MEG3 inhibit endometrial carcinoma tumorigenesis and progression through PI3K pathway. |
| Q98386342 | LncRNA MEG3 inhibits non-small cell lung cancer via interaction with DKC1 protein |
| Q92610047 | LncRNA MEG3 inhibits rheumatoid arthritis through miR-141 and inactivation of AKT/mTOR signalling pathway |
| Q64976070 | LncRNA MEG3 overexpression inhibits the development of diabetic retinopathy by regulating TGF-β1 and VEGF. |
| Q92644394 | LncRNA MEG3 promotes melanoma growth, metastasis and formation through modulating miR-21/E-cadherin axis |
| Q90481235 | LncRNA NRON promotes the proliferation, metastasis and EMT process in bladder cancer |
| Q41958683 | LncRNA and mRNA interaction study based on transcriptome profiles reveals potential core genes in the pathogenesis of human glioblastoma multiforme. |
| Q39009966 | LncRNA as a Therapeutic Target for Angiogenesis |
| Q92376700 | LncRNAs Regulatory Networks in Cellular Senescence |
| Q28081981 | LncRNAs: emerging players in gene regulation and disease pathogenesis |
| Q35204336 | Localization and abundance analysis of human lncRNAs at single-cell and single-molecule resolution |
| Q28730015 | Localizing transcriptional regulatory elements at the mouse Dlk1 locus |
| Q26752457 | Long Non-Coding RNAs As Potential Novel Prognostic Biomarkers in Colorectal Cancer |
| Q28071872 | Long Non-coding RNAs in Urologic Malignancies: Functional Roles and Clinical Translation |
| Q93062754 | Long Noncoding RNA-Maternally Expressed Gene 3 Contributes to Hypoxic Pulmonary Hypertension |
| Q41408442 | Long Noncoding RNAs Act as Novel Biomarkers for Hepatocellular Carcinoma: Progress and Prospects |
| Q47393672 | Long Noncoding RNAs as a Key Player in Hepatocellular Carcinoma |
| Q49721765 | Long Noncoding RNAs: New Players in the Osteogenic Differentiation of Bone Marrow- and Adipose-Derived Mesenchymal Stem Cells. |
| Q38633650 | Long non-coding RNA Fer-1-like family member 4 is overexpressed in human glioblastoma and regulates the tumorigenicity of glioma cells |
| Q33684959 | Long non-coding RNA GAS5 inhibits cell proliferation, induces G0/G1 arrest and apoptosis, and functions as a prognostic marker in colorectal cancer |
| Q55085420 | Long non-coding RNA LSINCT5 promotes ovarian cancer cell proliferation, migration and invasion by disrupting the CXCL12/CXCR4 signalling axis. |
| Q35930137 | Long non-coding RNA MEG3 functions as a competing endogenous RNA to regulate gastric cancer progression |
| Q35010490 | Long non-coding RNA MEG3 inhibits NSCLC cells proliferation and induces apoptosis by affecting p53 expression |
| Q41676843 | Long non-coding RNA MEG3 inhibits the proliferation and metastasis of oral squamous cell carcinoma by regulating the WNT/β-catenin signaling pathway |
| Q96133985 | Long non-coding RNA MEG3 is involved in osteogenic differentiation and bone diseases (Review) |
| Q92645402 | Long non-coding RNA MEG3 mediates high glucose-induced endothelial cell dysfunction |
| Q58735655 | Long non-coding RNA MEG3 suppresses survival, migration, and invasion of cervical cancer |
| Q42365283 | Long non-coding RNA ZFAS1 correlates with clinical progression and prognosis in cancer patients |
| Q36790436 | Long non-coding RNA in cancer |
| Q64071856 | Long non-coding RNA in osteogenesis: A new world to be explored |
| Q48655385 | Long non-coding RNA taurine upregulated 1 enhances tumor-induced angiogenesis through inhibiting microRNA-299 in human glioblastoma. |
| Q40581541 | Long non-coding RNA: A new paradigm for lung cancer |
| Q33739712 | Long non-coding RNA: Functional agent for disease traits |
| Q34607635 | Long non-coding RNAs and hepatocellular carcinoma |
| Q38065895 | Long non-coding RNAs and p53 regulation. |
| Q34267035 | Long non-coding RNAs differentially expressed between normal versus primary breast tumor tissues disclose converse changes to breast cancer-related protein-coding genes |
| Q47138075 | Long non-coding RNAs in Colorectal Cancer: Progression and Future Directions |
| Q64285898 | Long non-coding RNAs in Oral squamous cell carcinoma: biologic function, mechanisms and clinical implications |
| Q26774282 | Long non-coding RNAs in colorectal cancer |
| Q37139037 | Long non-coding RNAs in haematological malignancies. |
| Q49959192 | Long non-coding RNAs in ischemic stroke. |
| Q34998371 | Long non-coding RNAs in non-small cell lung cancer as biomarkers and therapeutic targets |
| Q37580402 | Long non-coding RNAs: novel prognostic biomarkers for liver metastases in patients with early stage colorectal cancer |
| Q37249139 | Long non-coding RNAs: novel targets for nervous system disease diagnosis and therapy |
| Q38966959 | Long noncoding RNA (lincRNA), a new paradigm in gene expression control |
| Q53229252 | Long noncoding RNA GAS5 affects cell proliferation and predicts a poor prognosis in patients with colorectal cancer. |
| Q52694946 | Long noncoding RNA GAS5 promotes bladder cancer cells apoptosis through inhibiting EZH2 transcription. |
| Q36871225 | Long noncoding RNA HOTAIR is a prognostic marker for esophageal squamous cell carcinoma progression and survival |
| Q93185066 | Long noncoding RNA LINC00673 promotes the proliferation and metastasis of epithelial ovarian cancer by associating with opioid growth factor receptor |
| Q91451398 | Long noncoding RNA LINC01111 suppresses pancreatic cancer aggressiveness by regulating DUSP1 expression via microRNA-3924 |
| Q37733191 | Long noncoding RNA LINC01296 is associated with poor prognosis in prostate cancer and promotes cancer-cell proliferation and metastasis |
| Q48038472 | Long noncoding RNA MEG3 induces cholestatic liver injury by interaction with PTBP1 to facilitate shp mRNA decay |
| Q57035109 | Long noncoding RNA MEG3 regulates LATS2 by promoting the ubiquitination of EZH2 and inhibits proliferation and invasion in gallbladder cancer |
| Q92319477 | Long noncoding RNA-MEG3 contributes to myocardial ischemia-reperfusion injury through suppression of miR-7-5p expression |
| Q38639536 | Long noncoding RNAs and tumorigenesis: genetic associations, molecular mechanisms, and therapeutic strategies |
| Q35747814 | Long noncoding RNAs in development and cancer: potential biomarkers and therapeutic targets |
| Q38996024 | Long noncoding RNAs in head and neck cancer |
| Q38241983 | Long noncoding RNAs in liver cancer: what we know in 2014. |
| Q37113177 | Long noncoding RNAs in prostate cancer: overview and clinical implications |
| Q38638146 | Long noncoding RNAs in regulation of human breast cancer |
| Q39042974 | Long noncoding RNAs in the p53 network. |
| Q34982521 | Long noncoding RNAs(lncRNAs) and the molecular hallmarks of aging |
| Q47144390 | Long noncoding RNAs: a new regulatory code in osteoarthritis |
| Q38682910 | Long noncoding RNAs: emerging regulators of tumor angiogenesis |
| Q38944003 | Long noncoding and circular RNAs in lung cancer: advances and perspectives |
| Q34474525 | Loss of imprinting and allelic switching at the DLK1-MEG3 locus in human hepatocellular carcinoma |
| Q55050306 | MEG3 Activated by Vitamin D Inhibits Colorectal Cancer Cells Proliferation and Migration via Regulating Clusterin. |
| Q50090394 | MEG3 Long Noncoding RNA Contributes to the Epigenetic Regulation of Epithelial-Mesenchymal Transition in Lung Cancer Cell Lines. |
| Q38653846 | MEG3 is a prognostic factor for CRC and promotes chemosensitivity by enhancing oxaliplatin-induced cell apoptosis |
| Q37400271 | MEG3, HCN3 and linc01105 influence the proliferation and apoptosis of neuroblastoma cells via the HIF-1α and p53 pathways |
| Q63561058 | MEG3, as a Competing Endogenous RNA, Binds with miR-27a to Promote PHLPP2 Protein Translation and Impairs Bladder Cancer Invasion |
| Q92002429 | MEG3-derived miR-493-5p overcomes the oncogenic feature of IGF2-miR-483 loss of imprinting in hepatic cancer cells |
| Q88637044 | MEG3/miR‑21 axis affects cell mobility by suppressing epithelial‑mesenchymal transition in gastric cancer |
| Q91825023 | MEG8 long noncoding RNA contributes to epigenetic progression of the epithelial-mesenchymal transition of lung and pancreatic cancer cells |
| Q36087352 | Mammalian Ste20-like kinase 4 promotes pituitary cell proliferation and survival under hypoxia |
| Q37601037 | Maternal blood lead concentrations, DNA methylation of MEG3 DMR regulating the DLK1/MEG3 imprinted domain and early growth in a multiethnic cohort |
| Q91627185 | Metabolic changes during malignant transformation in primary cells of oral lichen planus: Succinate accumulation and tumour suppression |
| Q53099225 | Methylation-mediated downregulation of long noncoding RNA LOC100130476 in gastric cardia adenocarcinoma. |
| Q64102254 | MicroRNA-26b-5p Inhibits Mouse Liver Fibrogenesis and Angiogenesis by Targeting PDGF Receptor-Beta |
| Q38931172 | Mouse models of Down syndrome: gene content and consequences |
| Q86736236 | Multiple endocrine neoplasia type 1 |
| Q36852725 | Neighborhood and Family Environment of Expectant Mothers May Influence Prenatal Programming of Adult Cancer Risk: Discussion and an Illustrative DNA Methylation Example |
| Q37445958 | New Perspectives on Genomic Imprinting, an Essential and Multifaceted Mode of Epigenetic Control in the Developing and Adult Brain |
| Q38475233 | New insights into polar overdominance in callipyge sheep |
| Q38189361 | Non-coding RNAs as epigenetic regulator of glioma stem-like cell differentiation |
| Q34254370 | Non-coding RNAs in cerebral endothelial pathophysiology: emerging roles in stroke |
| Q38283288 | Non-coding RNAs: biological functions and applications. |
| Q26786557 | Noncoding RNA control of cellular senescence |
| Q38885486 | Noncoding RNAs in Tumor Angiogenesis |
| Q26752617 | Novel Insights into the Role of Long Noncoding RNA in Ocular Diseases |
| Q93101939 | Overexpression of LncRNA GHET1 predicts an unfavourable survival and clinical parameters of patients in various cancers |
| Q38856618 | Overexpression of Long Non-Coding RNA MEG3 Inhibits Proliferation of Hepatocellular Carcinoma Huh7 Cells via Negative Modulation of miRNA-664. |
| Q39012257 | Overexpression of long non-coding RNA HOTAIR predicts poor patient prognosis and promotes tumor metastasis in epithelial ovarian cancer |
| Q38800573 | Overexpression of long non-coding RNA LOC400891 promotes tumor progression and poor prognosis in prostate cancer |
| Q38699563 | Overexpression of long non-coding RNA MEG3 suppresses breast cancer cell proliferation, invasion, and angiogenesis through AKT pathway |
| Q58560786 | Overexpression of long non‑coding RNA n346372 in bladder cancer tissues is associated with a poor prognosis |
| Q50523894 | PTENP1 acts as a ceRNA to regulate PTEN by sponging miR-19b and explores the biological role of PTENP1 in breast cancer. |
| Q34471303 | Pan-cancer transcriptome analysis reveals long noncoding RNAs with conserved function |
| Q89684134 | Pan-tissue transcriptome analysis of long noncoding RNAs in the American beaver Castor canadensis |
| Q53358942 | Paternal uniparental disomy chromosome 14-like syndrome due a maternal de novo 160 kb deletion at the 14q32.2 region not encompassing the IG- and the MEG3-DMRs: Patient report and genotype-phenotype correlation. |
| Q93090434 | Pathway analysis of a genome‑wide association study on a long non‑coding RNA expression profile in oral squamous cell carcinoma |
| Q58758844 | Periconceptional Maternal Mediterranean Diet Is Associated With Favorable Offspring Behaviors and Altered CpG Methylation of Imprinted Genes |
| Q42700665 | Potential applications of MEG3 in cancer diagnosis and prognosis |
| Q33670900 | Profiling of long non-coding RNAs identifies LINC00958 and LINC01296 as candidate oncogenes in bladder cancer |
| Q37628967 | Prognostic value of long non-coding RNA UCA1 in human solid tumors |
| Q28074528 | Progress of Long Non-coding RNAs in Non-small Cell Lung Cancer |
| Q97883364 | Rare Germline DICER1 Variants in Pediatric Patients With Cushing's Disease: What Is Their Role? |
| Q27011533 | Regulation of mammary epithelial cell homeostasis by lncRNAs |
| Q38097516 | Regulation of snoRNAs in cancer: close encounters with interferon |
| Q36677764 | Regulatory mechanisms of long noncoding RNAs in vertebrate central nervous system development and function |
| Q40550308 | Regulatory role of small nucleolar RNAs in human diseases. |
| Q91928822 | Reverse-genetics studies of lncRNAs-what we have learnt and paths forward |
| Q57297217 | Role of flow-sensitive microRNAs and long noncoding RNAs and in vascular dysfunction and atherosclerosis |
| Q64355505 | Role of flow-sensitive microRNAs and long noncoding RNAs in vascular dysfunction and atherosclerosis |
| Q38951145 | Role of long non-coding RNAs in the determination of β-cell identity |
| Q90329037 | Role of pyroptosis in cardiovascular disease |
| Q38203736 | Role of the lncRNA-p53 regulatory network in cancer |
| Q99561822 | Roles of Noncoding RNAs in Islet Biology |
| Q35567632 | Roles of long non-coding RNAs in gastric cancer metastasis |
| Q47099122 | Roles of miRNAs and long noncoding RNAs in the progression of diabetic retinopathy |
| Q39398940 | SPRY4-IT1: A novel oncogenic long non-coding RNA in human cancers |
| Q90699354 | Screening for long noncoding RNAs associated with oral squamous cell carcinoma reveals the potentially oncogenic actions of DLEU1 |
| Q37716132 | Shining the Light on Senescence Associated LncRNAs |
| Q38688209 | Single-cell RNA sequencing reveals an altered gene expression pattern as a result of CRISPR/cas9-mediated deletion of Gene 33/Mig6 and chronic exposure to hexavalent chromium in human lung epithelial cells |
| Q40414194 | Skp2 regulates non-small cell lung cancer cell growth by Meg3 and miR-3163. |
| Q57018188 | Snail mediates repression of the Dlk1-Dio3 locus in lung tumor-infiltrating immune cells |
| Q92422983 | Specific and Non-Specific Biomarkers in Neuroendocrine Gastroenteropancreatic Tumors |
| Q46824742 | Sperm DNA methylation analysis in swine reveals conserved and species-specific methylation patterns and highlights an altered methylation at the GNAS locus in infertile boars |
| Q35731289 | TODRA, a lncRNA at the RAD51 Locus, Is Oppositely Regulated to RAD51, and Enhances RAD51-Dependent DSB (Double Strand Break) Repair |
| Q92839390 | Targeting long non-coding RNA HERC2P3 inhibits cell growth and migration in human gastric cancer cells |
| Q38752040 | Targeting noncoding RNAs in disease |
| Q33627977 | The Activity-Induced Long Non-Coding RNA Meg3 Modulates AMPA Receptor Surface Expression in Primary Cortical Neurons. |
| Q35680700 | The Long Noncoding RNA MEG3 Is Downregulated and Inversely Associated with VEGF Levels in Osteoarthritis |
| Q33828371 | The Missing lnc(RNA) between the pancreatic β-cell and diabetes |
| Q58694197 | The Network of Non-coding RNAs in Cancer Drug Resistance |
| Q92137481 | The Regulatory Roles of Long Noncoding RNAs in Acute Myeloid Leukemia |
| Q92852980 | The Role of Epigenetics in Placental Development and the Etiology of Preeclampsia |
| Q38914193 | The aberrant expression of MEG3 regulated by UHRF1 predicts the prognosis of hepatocellular carcinoma |
| Q37356325 | The complexity of bladder cancer: long noncoding RNAs are on the stage |
| Q38626016 | The emerging role of lncRNAs in cancer |
| Q39022806 | The emerging role of long non-coding RNA in gallbladder cancer pathogenesis. |
| Q28392415 | The long non-coding RNA ANRIL promotes proliferation and cell cycle progression and inhibits apoptosis and senescence in epithelial ovarian cancer |
| Q38896754 | The long non-coding RNA HOTAIR promotes the proliferation of serous ovarian cancer cells through the regulation of cell cycle arrest and apoptosis |
| Q61796082 | The long non-coding RNA Meg3 is dispensable for hematopoietic stem cells |
| Q51751763 | The long non-coding RNA maternally expressed gene 3 activates p53 and is downregulated in esophageal squamous cell cancer. |
| Q28271675 | The microRNAs within the DLK1-DIO3 genomic region: involvement in disease pathogenesis |
| Q26830047 | The molecular pathogenesis of pituitary adenomas: an update |
| Q37401950 | The paternally imprinted DLK1-GTL2 locus is differentially methylated in embryonal and alveolar rhabdomyosarcomas |
| Q38274982 | The role of genetic and epigenetic changes in pituitary tumorigenesis |
| Q38630563 | The role of lncRNAs in hepatocellular carcinoma: opportunities as novel targets for pharmacological intervention. |
| Q90482676 | The role of noncoding RNAs in epithelial cancer |
| Q59791075 | The roles of lncRNA in hepatic fibrosis |
| Q49961986 | Therapeutic Targeting of Long Non-Coding RNAs in Cancer. |
| Q34530150 | Transcriptome-wide profiling and posttranscriptional analysis of hematopoietic stem/progenitor cell differentiation toward myeloid commitment |
| Q36161900 | Tumor suppression by MEG3 lncRNA in a human pituitary tumor derived cell line |
| Q39196669 | Upregulated H19 contributes to bladder cancer cell proliferation by regulating ID2 expression. |
| Q50954583 | Upregulated lncRNA-PCAT1 is closely related to clinical diagnosis of multiple myeloma as a predictive biomarker in serum. |
| Q41262517 | Upregulation of lncRNA MEG3 Promotes Osteogenic Differentiation of Mesenchymal Stem Cells From Multiple Myeloma Patients By Targeting BMP4 Transcription |
| Q36355609 | Urinary long noncoding RNAs in nonmuscle-invasive bladder cancer: new architects in cancer prognostic biomarkers. |
| Q38581149 | Urothelial cancer associated 1: a long noncoding RNA with a crucial role in cancer |
| Q95832005 | Visualizing the functional 3D shape and topography of long noncoding RNAs by single-particle atomic force microscopy and in-solution hydrodynamic techniques |
| Q52752598 | [Non-coding RNA : Innovative regulators with therapeutic perspective]. |
| Q52721285 | lncRNA Epigenetic Landscape Analysis Identifies EPIC1 as an Oncogenic lncRNA that Interacts with MYC and Promotes Cell-Cycle Progression in Cancer. |
| Q59804839 | lncRNA MEG3 promotes hepatic insulin resistance by serving as a competing endogenous RNA of miR-214 to regulate ATF4 expression |
| Q91712585 | lncRNA MIAT promotes cell invasion and migration in esophageal cancer |
| Q39012355 | lncRNAs: novel players in intervertebral disc degeneration and osteoarthritis |
| Q57470836 | locus-derived LncRNAs perpetuate postmitotic motor neuron cell fate and subtype identity |
| Q58553627 | miR-506 attenuates methylation of lncRNA to inhibit migration and invasion of breast cancer cell lines via targeting SP1 and SP3 |
| Q40120040 | microRNA dependent and independent deregulation of long non-coding RNAs by an oncogenic herpesvirus. |
| Q35797313 | ncRDeathDB: A comprehensive bioinformatics resource for deciphering network organization of the ncRNA-mediated cell death system |
Search more.